Q-omics provides the consensus-scored ELL2P4 profile across patient tissues and cancer cell-line models. ELL2P4 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, ELL2P4 RNA expression shows 5,419 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight LUAD, and UCEC as cancer lineages where ELL2P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.